Posted by: davidjolson | 04/26/2011

WHO trying to accommodate NGOs at NCD fora in Moscow

This guest blog was written by Jeff Meer of Public Health Institute and was originally published on Dialogue4Health, the blog of PHI.

MOSCOW, Russia  — As delegations gather this week to assess the state of the world’s non-communicable disease (NCD) epidemic and governments’ efforts to cope, advocates will be pressing to make sure that non-governmental organizations, corporations and academics all have a role in clarifying problems and identifying solutions.

All indications are that the United Nations, and in particular, the World Health Organization, is doing its utmost to accommodate the hundreds of organizations and individuals who want to be heard on the subject.  For example, this week’s First Global Ministerial Conference on Healthy Lifestyles and Non-Communicable Diseases will be videocast.  The WHO has nominated several individuals to act as “Rapporteurs” or note takers at this week’s Global Forum on NCDs that will precede the ministerial conference to gather civil society input better.  And provisions have been made to allow organizations previously unknown to the United Nations to participate in a “listening session” on NCDs in New York in June.

This stands in contrast to normal procedure at the United Nations, where organizations can wait for up to a year or more after submitting a request to learn whether they have been “accredited” to attend meetings of the Economic and Social Council, for example.

Nevertheless, some organizations continue to chafe at the process.  Space limitations dictate that only one representative per organization can attend the June event, and the full UN High Level Session on NCDs planned for September 19-20.  And uncertainties about visa processing means that some organizations have had to make strategic decisions months in advance about which representatives to register for these important gatherings.

In addition, the UN has still not named its civil society steering committee on NCDs, which is charged with — among other things  — deciding which organizations among the more than 700 registered are permitted to attend.


  1. PIHDO Dengue Awareness Campaign For Pakistani People 
    PIHDO, Panacea International Human Development Organization a non Governmental Organization (NGO) in islamabad has launched a comprehensive dengue awareness campaign regarding preventive measures against dengue virus in all the ICT , ISLAMABAD REGION . The PIHDO management has also directed all hospitals on its panels to provide best medical facilities to its People and their family members admitted with dengue fever.

    Dengue (DF) and dengue hemorrhagic fever (DHF) are caused by one of four closely related, but antigenically distinct, virus serotypes (DEN-1, DEN-2, DEN-3, and DEN-4), of the genus Flavivirus. Infection with one of these serotypes provides immunity to only that serotype for life, so persons living in a dengue-endemic area can have more than one dengue infection during their lifetime. DF and DHF are primarily diseases of tropical and sub tropical areas, and the four different dengue serotypes are maintained in a cycle that involves humans and the Aedes mosquito. However, Aedes aegypti, a domestic, day-biting mosquito that prefers to feed on humans, is the most common Aedes species. Infections produce a spectrum of clinical illness ranging from a nonspecific viral syndrome to severe and fatal hemorrhagic disease. Important risk factors for DHF include the strain of the infecting virus, as well as the age, and especially the prior dengue infection history of the patient.

    1.Fever, bladder problem, constant headaches, severe dizziness and loss of appetite.
    2.Hemorrhagic tendency (positive tourniquet test, spontaneous bruising, bleeding from mucosa, gingiva, injection sites, etc.; vomiting blood, or bloody diarrhea)
    3.Thrombocytopenia (<100,000 platelets per mm³ or estimated as less than 3 platelets per high power field)
    4.Evidence of plasma leakage (hematocrit more than 20% higher than expected, or drop in haematocrit of 20% or more from baseline following IV fluid, pleural effusion, ascites, hypoproteinemia)
    5.Encephalitic occurrences.
    Dengue shock syndrome is defined as dengue hemorrhagic fever plus:

    Weak rapid pulse,
    Narrow pulse pressure (less than 20 mm Hg)
    Cold, clammy skin and restlessness.
    dengue is caused by a virus, there is no specific medicine or antibiotic to treat it. For typical dengue, the treatment is purely concerned with relief of the symptoms (symptomatic). Rest and fluid intake for adequate hydration is important. Aspirin and nonsteroidal anti-inflammatory drugs should be avoided. Acetaminophen (Tylenol) and codeine may be given for severe headache and for the joint and muscle pain (myalgia).Typical dengue does not result in death. It is fatal in less than 1% of cases. The acute phase of the illness with fever and myalgias lasts about one to two weeks. Convalescence is accompanied by a feeling of weakness (asthenia), and full recovery often takes several weeks.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s


%d bloggers like this: